Disparities in Clinical Trial Access Across US Urban Areas-Reference-Cited by-同舟云学术

Disparities in Clinical Trial Access Across US Urban Areas

Published:2020-02-28 Issue:2 Volume:3 Page:e200172
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Feyman Yevgeniy¹²,Provenzano Frank¹³,David Frank S.¹

Affiliation:

1. Pharmagellan LLC, Milton, Massachusetts

2. Boston University School of Public Health, Boston, Massachusetts

3. Department of Neurology, Columbia University, New York, New York

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2762014/feyman_2020_ld_200001.pdf

Reference6 articles.

1. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation.;Unger;J Natl Cancer Inst,2019

2. Geographic distribution of clinical trials may lead to inequities in access.;Seidler;Clin Investig,2014

3. Bureau of Labor Statistics, US Department of Labor. Federal statistical area delineations. https://www.bls.gov/lau/lausmsa.htm. Accessed August 16, 2019.

4. US Office of Management and Budget. Revised delineations of metropolitan statistical areas, micropolitan statistical areas, and combined statistical areas, and guidance on uses of the delineations of these areas: OMB bulletin No. 17-01. https://www.bls.gov/bls/omb-bulletin-17-01-revised-delineations-of-metropolitan-statistical-areas.pdf. Accessed August 16, 2019.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CryoSCAPE: Scalable Immune Profiling Using Cryopreserved Whole Blood for Multi-omic Single Cell and Functional Assays;2024-08-21

2. Geographic and Racial Disparities in Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-05

3. Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions;Seminars in Radiation Oncology;2023-10

4. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities;International Journal of Drug Policy;2023-10

5. Diversity and Representation Among United States Participants in Amgen Clinical Trials;Journal of Racial and Ethnic Health Disparities;2023-09-27